A61B6/506

DISPLAY METHOD, AND DISPLAY CONTROL DEVICE
20190069866 · 2019-03-07 ·

A display control device includes an image acquisition unit, a position acquisition unit, an image displaying unit, an information acquisition unit, and an information displaying unit. The image displaying unit displays with a display device a target image, the target image being an image a position corresponding to a tool position. The information acquisition unit acquires the at least one medical support information associated with an acquired position that represents the position of the medical tool at a time when the medical support information was acquired. The information displaying unit performs an information display by associating, based on the acquired position associated with the at least one medical support information, the medical support information with a position on the target image and that displays the medical support information.

Wearable medical detector

Various embodiments of medical detector systems as well as their methods of operation are disclosed. In one embodiment, one or more detectors are coupled to wearable structures for detecting at least a first tracer within a body portion. In another embodiment, one or more detectors are coupled to a wearable structure, where the detector corresponds to a CMOS chip that directly detects a first radioactive tracer.

Optical Method for the Detection of Alzheimer's Disease

The present subject matter relates to a non-invasive optical imaging method for monitoring early pathological events specific to Alzheimer's disease (AD), such as the development, amount and location of amyloid plaques. The ability to monitor such events provides a basis for, among other things, AD diagnosis, prognosis and assessment of potential therapies. In addition, the present subject matter introduces novel methods for treating AD and retinal ailments associated with AD. A-plaque detection in living brains is extremely limited, especially at high resolution; therefore the present invention is based on studies focusing on the eyes as an alternative to brain-derived tissue that can be imaged directly, repetitively and non-invasively.

DIAGNOSTIC SUPPORT SYSTEM AND DIAGNOSTIC SUPPORT METHOD

A diagnostic support system includes a spinal cord/spinal nerve evoked magnetic field data acquisition device configured to acquire spinal cord/spinal nerve evoked magnetic field data and a medical image information acquisition device configured to acquire first medical image information having each pixel associated with a corresponding pixel of visualized data of the spinal cord/spinal nerve evoked magnetic field data. The diagnostic support system superimposes the visualized data of the spinal cord/spinal nerve evoked magnetic field data on second medical image information based on information included in the first medical image information.

Systems and methods for surgical and interventional planning, support, post-operative follow-up, and, functional recovery tracking

Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, data related to retraction of tissue can be gathered during performance of a surgical procedure. In one embodiment, the data can be used during performance of the surgical procedure, e.g., to determine whether a length of time a tissue is retracted using a retractor reaches a predetermined threshold amount of time, an amount of tissue retraction reaches a predetermined amount of tissue, and an amount of pressure being placed on tissue and/or nerves as a result of retraction reaches a predetermined amount of pressure, and/or the data can be used after performance of the surgical procedure, e.g., in determining a correlation between the data and patient pain level data.

RENAL ABLATION AND VISUALIZATION SYSTEM AND METHOD WITH COMPOSITE ANATOMICAL DISPLAY IMAGE
20180360342 · 2018-12-20 ·

A method and device that provide improved visualization of soft tissue, such as renal arteries, renal veins and lymph nodes in guiding catheter placement and positioning in the renal region or vasculature. The method and device enable visualization of an electrophysiology catheter application in the renal region which provides for improved imaging of renal structures, including renal arteries, along with one or more adjacent anatomical structures, including renal veins, lymph nodes, other adjacent organs and and/or other adjacent soft tissues that may adversely impact the formation of a lesion during a catheter ablation procedure in or around a renal artery.

Device and method for identifying anatomical structures

A method for identifying a target anatomy by use of a device having an ultrasound transducer. Using the ultrasound transducer, a portion of a patient's anatomy is scanned during a scanning process. A voltage trace of the patient's anatomy is determined and compared to a predetermined trace. If the voltage trace of the patient's anatomy matches the predetermined trace, a notification may be output.

SYSTEMS AND METHODS FOR SURGICAL AND INTERVENTIONAL PLANNING, SUPPORT, POST-OPERATIVE FOLLOW-UP, AND FUNCTIONAL RECOVERY TRACKING

Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, a patient can be tracked throughout medical treatment including through initial onset of symptoms, diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment. In one embodiment, a patient and one or more medical professionals involved with treating the patient can electronically access a comprehensive treatment planning, support, and review system. The system can provide recommendations regarding diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment based on data gathered from the patient and the medical professional(s). The system can manage the tracking of multiple patients, thereby allowing for data comparison between similar aspects of medical treatments and for learning over time through continual data gathering, analysis, and assimilation to decision-making algorithms.

SYSTEMS AND METHODS FOR SURGICAL AND INTERVENTIONAL PLANNING, SUPPORT, POST-OPERATIVE FOLLOW-UP, AND FUNCTIONAL RECOVERY TRACKING

Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, a patient can be tracked throughout medical treatment including through initial onset of symptoms, diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment. In one embodiment, a patient and one or more medical professionals involved with treating the patient can electronically access a comprehensive treatment planning, support, and review system. The system can provide recommendations regarding diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment based on data gathered from the patient and the medical professional(s). The system can manage the tracking of multiple patients, thereby allowing for data comparison between similar aspects of medical treatments and for learning over time through continual data gathering, analysis, and assimilation to decision-making algorithms.

Systems, compositions, and methods for local imaging and treatment of pain

Pain factors are labeled with targeted agents or markers delivered into the body. The labeled pain factors are imaged with appropriate imaging tools in a manner allowing selective identification and localization of areas of pain source or transmission. The labeled pain factors allow spatial differentiation in the imaging sufficient to specify the location of the pain so as to drive therapeutic decisions and techniques in order to treat the pain. Pain factors labeled and imaged in this manner may include one or more of nerve factors, blood vessel factors, cellular factors, and inflammation factors. Labeled markers may include for example radioactive materials (e.g. tritiated or iodinated molecules) or other materials such as metal (e.g. gold) nanoparticles. Intermediary binding materials may be used, such as for example bi-specific antibodies.